Global Neuroendoscopy Market Size, Share, and COVID-19 Impact Analysis, By Product (Rigid {Videoscope, Fiberscope}, Flexible Endoscope), By Usability (Reuse and Disposable), By Patient (Adult and Pediatric), By Application (Transnasal, Intraventricular, and Transcranial), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 – 2032.

Industry: Healthcare


Global Neuroendoscopy Market Insights Forecasts to 2032

  • The Global Neuroendoscopy Market Size was valued at USD 142.7 Million in 2022.
  • The Market Size is Growing at a CAGR of 5.5% from 2022 to 2032.
  • The Worldwide Neuroendoscopy Market size is expected to reach USD 245.5 Million by 2032.
  • Asia Pacific is expected To Grow the fastest during the forecast period.


Global Neuroendoscopy Market

Get more details on this report -

Request Free Sample PDF


The Global Neuroendoscopy Market Size is expected to reach USD 245.5 Million by 2032, at a CAGR of 5.5% during the forecast period 2022 to 2032.


Market Overview

Neuroendoscopy is a minimally invasive surgical treatment that is used to diagnose and treat neurological diseases that occur inside the brain, spinal cord, or adjacent tissues. To reach the target region, these gadgets integrate a thin, flexible tube with a light source and a camera connected to its tip. The increasing number of brain tumor patients throughout the world will increase the demand for and adoption rate of neuroendoscopy surgical treatments. Furthermore, malignancies such as auditory neuroma and craniopharyngioma, among others, will increase the frequency of neurosurgery procedures, fuelling the rise of the neuroendoscopy sector. Furthermore, growing efforts by key companies to provide innovative neuroendoscopes for a variety of neurological therapies are projected to drive the worldwide neuroendoscopy devices market throughout the forecast period. Furthermore, technological advancements in neuroendoscopes and rising demand for less invasive surgical procedures are expected to drive the growth of the worldwide neuroendoscopy devices market.


Report Coverage

This research report categorizes the global neuroendoscopy market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global neuroendoscopy market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global neuroendoscopy market. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market.


Global Neuroendoscopy Market Report Coverage

Report CoverageDetails
Base Year:2022
Market Size in 2022:USD 142.7 Million
Forecast Period:2022-2032
Forecast Period 2022-2032 CAGR:5.5%
2032 Value Projection:USD 245.5 Million
Historical Data for:2018-2021
No. of Pages:200
Tables, Charts & Figures:110
Segments covered:By Product, By Usability, By Patient, By Application, By Region.
Companies Covered: Adeor Medical AG, KARL STORZ SE & Co. KG, Medtronic, B. Braun SE, Olympus Corporation, BD, HOYA Corporation, Stryker, Boston Scientific Corporation, CONMED Corporation., Arthrex Inc., Aesculap, and Inc.
Pitfalls & Challenges:COVID-19 Empact, Challenge, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF

Driving Factors

The numerous benefits of flexible neuroendoscopy are expected to increase demand for flexible neuroendoscopes. One of the key benefits of flexible neuroendoscopes is their unstable shape, which allows them to be laid along a curved course. For example, Karl Storz GmbH created a "flexible video neuroendoscope" to treat hydrocephalus. It is the only visual neuroendoscope authorized by the Food and Drug Administration (FDA). As a result, this element drives market expansion. Also, there is an increasing number of technical breakthroughs that contribute to the market growth rate. The growing trend for less invasive operations has resulted in the development of improved neuro endoscopy devices. Several developments in endoscopic imaging and visualization devices have enabled surgeons to work more correctly and precisely. Furthermore, the advancement of 3D endoscopy technology and 4K ultra-high-definition displays has enhanced the imaging capabilities of neuro endoscopic procedures. As a result, this element contributes to market expansion.


Restraining Factors

Several difficulties are connected with neuro endoscopy, which causes market disruption. Complications from these operations include subdural hematoma, pneumocephalus, subdural hygroma, and damage to the basilar artery and hypothalamus. Furthermore, various side effects, such as bleeding, infections, or anesthetic responses, stymie market expansion. As a result, these barriers hinder market expansion.


Market Segmentation

  • In 2022, the rigid {videoscope, fiberscope} segment is dominating the market with the largest market share during the forecast period.

Based on product, the global neuroendoscopy market is bifurcated into different segments such as rigid {videoscope, fiberscope}, and flexible endoscope. Among these segments, the rigid {videoscope, and fiberscope} segment has the biggest revenue share over the predicted period. When introduced through a natural opening in the body, these tools provide a direct view of the sick region. Among the several advantages of rigid endoscopes are higher picture quality, greater maneuverability, access to deep-seated areas, and effective irrigation and suction. Furthermore, these items can handle a variety of surgical tools and have a longer lifespan, making them suited for frequent use and sterilization.


  • In 2022, the reuse segment is influencing the largest market share over the forecast period.

Based on usability, the global neuroendoscopy market is classified into reuse and disposable. Among these segments, the reuse segment is dominating the market due to variables such as the cost-effectiveness of reusable equipment, which may be utilized in several operations following purchase.


  • In 2022, the adult segment is dominating the market with the largest market share during the forecast period.

Based on patients, the global neuroendoscopy market is bifurcated into different segments such as adult and pediatric. Among these segments, the adult segment has the biggest revenue share over the predicted period due to the increasing age-related illnesses in the senior population necessitating endoscopy for disease diagnosis. The elderly are more likely to suffer from one or more illnesses, increasing the demand for neuroendoscopy.


  • In 2022, the intraventricular segment is influencing the largest market share over the forecast period.

Based on application, the global neuroendoscopy market is bifurcated into different segments such as transnasal, intraventricular, and transcranial. Among these segments, the intraventricular segment has the biggest revenue share during the forecast period due to the increasing occurrence of neurological illnesses, brain tumors, and biopsies, as well as the growing elderly population, among other factors. Intraventricular neuro endoscopy is a minimally invasive surgical treatment that includes utilizing a tiny endoscope to visualize and treat various neurological problems within the brain's ventricles. Neuroendoscopy can be used to access and biopsy intraventricular tumors such as colloid cysts or ependymomas. The neuro endoscope provides a good picture of the tumor, allowing for a more precise sample for pathological examination.


Regional Segment Analysis of the neuroendoscopy market

  • North America (U.S., Canada, Mexico) 
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Rest of APAC)
  • South America (Brazil and the Rest of South America) 
  • The Middle East and Africa (UAE, South Africa, Rest of MEA)


  • North America is dominating the market with the largest market revenue share during the forecast period


Global Neuroendoscopy Market

Get more details on this report -

Request Free Sample PDF


North America is leading the significant market growth during the forecast period. This market share is due to a variety of factors, including the existence of significant market players, growth in the number of neurological disorders, and increased knowledge about the benefits of neuro endoscopy for diagnosis and treatment of these conditions, among others.


In Asia Pacific, the market for neuroendoscopy market is predicted to develop rapidly over the forecast period owing to the increasing prevalence of brain tumors, together with an increase in the number of biopsies performed in medical institutions, which is expected to drive regional market growth. Furthermore, increased healthcare spending in emerging nations such as Vietnam, India, and others is likely to promote Asia Pacific market growth.


Competitive Analysis

The report offers the appropriate analysis of the key organizations/companies involved within the global neuroendoscopy market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.


List of Key Companies

  • Adeor Medical AG
  • Medtronic
  • B. Braun SE
  • Olympus Corporation
  • BD
  • HOYA Corporation
  • Stryker
  • Boston Scientific Corporation
  • CONMED Corporation.
  • Arthrex Inc.
  • Aesculap, Inc.


Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting And Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)


Recent Development

  • In August 2021, Adeor Medical AG announced a strategic agreement with ClearPoint Neuro, Inc., a worldwide therapy-enabling platform firm that provides navigation and delivery to the brain. ClearPoint Neuro, Inc. distributed medical devices and equipment for neurosurgery in the United States as part of this cooperation. This strategic collaboration aided the corporation in expanding its consumer base and increasing its business income.


Market Segment

This study forecasts revenue at global, regional, and country levels from 2022 to 2032. Spherical Insights has segmented the Global Neuroendoscopy Market based on the below-mentioned segments:


Global Neuroendoscopy Market, By Product

  • Rigid {Videoscope, Fiberscope}
  • Flexible endoscope


Global Neuroendoscopy Market, By Usability

  • Reuse
  • Disposable


Global Neuroendoscopy Market, By Patient

  • Adult
  • Pediatric


Global Neuroendoscopy Market, By Application

  • Transnasal
  • Intraventricular
  • Transcranial


Neuroendoscopy Market, By Regional Analysis

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • Uk
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies